Drägerwerk AG & Co. KGaA (XTRA:DRW3) acquired 67.32% stake in STIMIT AG on April 1, 2021. STIMIT will work together with Dräger in the following months to further develop the product and conduct clinical trials.

Drägerwerk AG & Co. KGaA (XTRA:DRW3) completed the acquisition of 67.32% stake in STIMIT AG for €5 million on April 1, 2021. As part of the acquisition, Drägerwerk takeover of cash in the amount of €0.09 million.